title: Clinical features and endothelin receptor antagonist in primary Sjögren's syndrome with pulmonary arterial hypertension.
authors.forename: C-H
authors.initials: CH
authors.lastname: Chen
authors.forename: H-A
authors.initials: HA
authors.lastname: Chen
authors.forename: K-Y
authors.initials: KY
authors.lastname: Yang
authors.forename: W-C
authors.initials: WC
authors.lastname: Yu
authors.forename: H-T
authors.initials: HT
authors.lastname: Liao
authors.forename: D-F
authors.initials: DF
authors.lastname: Huang
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D005260:Female; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000209:etiology*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008875:Middle Aged; D012859:Sjogren's Syndrome / Q000150:complications* / Q000188:drug therapy; D013449:Sulfonamides / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D007166:Immunosuppressive Agents; D013449:Sulfonamides; D000077300:Bosentan